Press Releases
Press Release
United Kingdom’s National Institute for Health and Care Excellence (NICE) Recommends NanoString’s Prosigna Breast Cancer Gene Signature Assay to Guide Chemotherapy Treatment Decisions for Qualified Early-Stage Invasive Breast Cancer Patients
SEATTLE, Dec. 19, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that health officials from…
Press Release
NanoString Technologies Highlights Advances in Precision Oncology at the 60th Annual Meeting of the American Society of Hematology
40+ Abstracts Highlight the Value of the nCounter Platform in Hematology & Immuno-oncology, Including Thirteen that Demonstrate the Potential Utility of the LymphMark Lymphoma Subtyping TestSEATTLE, Nov. 29, 2018 (GLOBE…
Press Release
NanoString to Present at the Evercore ISI HEALTHCONx Conference
SEATTLE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management…
Press Release
NanoString Technologies Releases Operating Results for Third Quarter of 2018
SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the…
Press Release
NanoString Announces Launch of CAR-T Characterization Panel for use in Development and Manufacturing
SEATTLE, Nov. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a…
Press Release
NanoString Highlights Research Presented at the 2018 Annual Meeting of the Society of Immunotherapy for Cancer (SITC)
Includes Data from More than Twenty-Five Studies, Including Six Using GeoMx Digital Spatial ProfilerSEATTLE, Nov. 07, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for…
Press Release
NanoString to Present at the 2018 Canaccord Medical Technologies and Diagnostics Forum
SEATTLE, Nov. 05, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company’s management…
Press Release
NanoString Highlights Advances in Product Pipeline and Application Development at the 2018 Association of Molecular Pathology Conference
Demonstrates Potential of Hyb & Seq NGS Platform for Infectious Disease ApplicationsSEATTLE, Oct. 30, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational…
Press Release
MacroGenics and NanoString Enter Translational Research Collaboration to Identify and Develop Biomarkers in Immuno-Oncology
Translational Research Initiative Will Use PanCancer IO 360 Panel to Identify Predictive Signatures for MGD013SEATTLE, Oct. 29, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools…
Press Release
NanoString Announces $100 Million Term Loan Facility with CRG
SEATTLE, Oct. 15, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has entered…
Press Release
Landmark Publications in Nature Medicine use NanoString’s Digital Spatial Profiling Platform to Discover Novel Insights in Immuno-Oncology
Two Independent Studies Use the GeoMx Digital Spatial Profiler to Investigate the Role of the Tumor and Micro-environment in Immunotherapy ResponseSEATTLE, Oct. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc.…
Press Release
NanoString to Release Third Quarter 2018 Financial Results and Host Conference Call on Thursday, November 8, 2018
SEATTLE, Oct. 08, 2018 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the Company will…